Addex Therapeutics Ltd (SWX:ADXN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
0.0446
-0.0004 (-0.89%)
Mar 12, 2026, 5:30 PM CET

Addex Therapeutics Balance Sheet

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
2.193.343.876.9620.4818.7
Short-Term Investments
0.010.01000.020.06
Cash & Short-Term Investments
2.193.353.876.9620.518.76
Cash Growth
-34.59%-13.40%-44.45%-66.05%9.29%-40.54%
Accounts Receivable
0.050.020.110.420.160.07
Other Current Assets
0.120.180.260.451.28-
Total Current Assets
2.363.544.237.8321.9419.49
Net Property, Plant & Equipment
0.040.040.350.40.540.63
Long-Term Investments
0.010.010.050.050.060.06
Total Assets
7.3310.684.648.2822.5420.18
Accounts Payable
1.170.792.3833.852.49
Current Portion of Leases
0.010.010.270.290.290.31
Unearned Revenue
--0.23--0.09
Total Current Liabilities
1.170.82.893.284.133.62
Long-Term Leases
0.030.030.070.090.190.26
Other Long-Term Liabilities
0.170.160.53-1.281.69
Total Long-Term Liabilities
0.20.20.60.091.481.95
Total Liabilities
1.3713.53.375.615.57
Common Stock
1.841.841.841.1549.2732.85
Treasury Stock
-0.68-0.87-0.91-6.28-11.7-6.08
Additional Paid-in Capital
267.25266.38266.19269.51283.98286.89
Accumulated Other Comprehensive Income
95.8195.6894.4490.3924.4414.66
Retained Earnings
-358.25-353.36-360.42-349.86-329.06-313.71
Shareholders' Equity
5.969.681.154.9116.9314.61
Total Liabilities & Equity
7.3310.684.648.2822.5420.18
Total Debt
0.040.040.340.370.480.57
Net Cash (Debt)
2.163.313.526.5920.0218.19
Net Cash Growth
-34.74%-6.13%-46.53%-67.10%10.04%-41.32%
Net Cash Per Share
1.502.372.859.6170.411636.40
Book Value
5.969.681.154.9116.9314.61
Book Value Per Share
4.166.930.937.1759.551314.14
Tangible Book Value
5.969.681.154.9116.9314.61
Tangible Book Value Per Share
4.166.930.937.1759.551314.14
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.